1. Home
  2. ESQ vs GHRS Comparison

ESQ vs GHRS Comparison

Compare ESQ & GHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Esquire Financial Holdings Inc.

ESQ

Esquire Financial Holdings Inc.

HOLD

Current Price

$100.73

Market Cap

944.4M

Sector

Finance

ML Signal

HOLD

Logo GH Research PLC

GHRS

GH Research PLC

HOLD

Current Price

$14.81

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ESQ
GHRS
Founded
2006
2018
Country
United States
Ireland
Employees
N/A
N/A
Industry
Commercial Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
944.4M
1.0B
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
ESQ
GHRS
Price
$100.73
$14.81
Analyst Decision
Buy
Strong Buy
Analyst Count
2
8
Target Price
$118.00
$39.75
AVG Volume (30 Days)
60.3K
176.4K
Earning Date
04-23-2026
01-01-0001
Dividend Yield
0.78%
N/A
EPS Growth
4.68
N/A
EPS
4.32
N/A
Revenue
N/A
N/A
Revenue This Year
$22.47
N/A
Revenue Next Year
$10.25
N/A
P/E Ratio
$23.88
N/A
Revenue Growth
N/A
N/A
52 Week Low
$69.14
$7.98
52 Week High
$119.86
$19.51

Technical Indicators

Market Signals
Indicator
ESQ
GHRS
Relative Strength Index (RSI) 41.64 48.04
Support Level $99.97 $11.84
Resistance Level $106.32 $16.24
Average True Range (ATR) 3.98 0.86
MACD -0.90 -0.04
Stochastic Oscillator 17.43 35.56

Price Performance

Historical Comparison
ESQ
GHRS

About ESQ Esquire Financial Holdings Inc.

Esquire Financial Holdings Inc is a financial holding company. Through its subsidiary, the company operates as a full-service commercial bank dedicated to serving the financial needs of the legal industry and small businesses nationally, as well as commercial and retail customers in the New York metropolitan area. The Bank offers tailored products and solutions to the legal community and their clients as well as dynamic and flexible payment processing solutions to small business owners. Banking products offered for businesses and consumers include checking, savings, money market, and time deposits; a wide range of commercial and consumer loans, as well as customary banking services. In addition, it operates a payment processing platform through third-party independent sales organizations.

About GHRS GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

Share on Social Networks: